COMMUNITY HEALTH SYSTEMS, INC. - FORM 8-K
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
July 26, 2006
Date of Report (date of earliest event reported)
 
COMMUNITY HEALTH SYSTEMS, INC.
(Exact name of Registrant as specified in charter)
 
         
Delaware   001-15925   13-3893191
         
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)
7100 Commerce Way, Suite 100
Brentwood, Tennessee 37027
(Address of principal executive offices)
Registrant’s telephone number, including area code: (615) 465-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240 .14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

     The information contained in this Form 8-K (including the exhibits hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
ITEM 2.02 Results of Operations and Financial Condition
     On July 26, 2006, Community Health Systems, Inc. (“the Company”) announced operating results for the quarter and six months ended June 30, 2006. A copy of the press release making this announcement is attached as Exhibit 99.1 to this Form 8-K.
ITEM 7.01 Regulation FD Disclosure
     On July 26, 2006, the Company announced among other matters an update to its previous 2006 guidance. A copy of the press release making this announcement is attached as Exhibit 99.1 to this Form 8-K.
ITEM 9.01 Financial Statements and Exhibits
     Exhibits
     The following exhibit is furnished herewith:
     99.1 Community Health Systems, Inc. Press Release dated July 26, 2006.
SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
         
Date: July 26, 2006  COMMUNITY HEALTH SYSTEMS, INC.
(Registrant)
 
 
  By:   /s/ Wayne T. Smith    
    Wayne T. Smith   
    Chairman of the Board,
President and Chief Executive Officer
(principal executive officer) 
 
 
     
  By:   /s/ W. Larry Cash    
    W. Larry Cash   
    Executive Vice President, Chief Financial
Officer and Director
(principal financial officer) 
 
 
     
  By:   /s/ T. Mark Buford    
    T. Mark Buford   
    Vice President and Corporate Controller (principal accounting officer)   

2


 

         
Index to Exhibits
     
Exhibit Number
  Description
 
   
 
   
99.1
  Press Release dated July 26, 2006

3

exv99w1
 

Exhibit Number
99.1
(commlogo)
Investor Contact:   W. Larry Cash
Executive Vice President
and Chief Financial Officer
(615) 465-7000
COMMUNITY HEALTH SYSTEMS, INC. ANNOUNCES
SECOND QUARTER 2006 RESULTS WITH NET OPERATING REVENUES UP 15.5%
 
BRENTWOOD, TN. (July 26, 2006) — Community Health Systems, Inc. (NYSE: CYH) today announced financial and operating results for the second quarter and six months ended June 30, 2006.
     Net operating revenues for the quarter ended June 30, 2006, totaled $1.061 billion, a 15.5% increase compared with $918.7 million for the same period last year. Income from continuing operations increased 13.5% to $52.4 million, or $0.54 per share (diluted), on 96.9 million weighted average shares outstanding for the quarter ended June 30, 2006, compared with $46.2 million, or $0.49 per share (diluted), on 99.3 million weighted average shares outstanding for the same period last year. Net income increased to $52.4 million, or $0.54 per share (diluted), for the quarter ended June 30, 2006, compared with $40.5 million, or $0.43 per share (diluted), for the same period last year.
     The second quarter 2006 results include additional compensation expense of $3.8 million, or $0.03 per diluted share, resulting from stock-based compensation calculated under SFAS No. 123(R), “Share-Based Payment”.
     Adjusted EBITDA for the second quarter of 2006 was $156.7 million, compared with $140.2 million for the same period last year, representing an 11.8% increase. Adjusted EBITDA is EBITDA adjusted to exclude discontinued operations and minority interest in earnings. The Company uses adjusted EBITDA as a measure of liquidity. Net cash provided by operating activities for the second quarter of 2006 was $116.2 million, compared with $127.7 million for the same period last year.
     The consolidated financial results for the quarter ended June 30, 2006, reflect a 10.5% increase in total admissions compared with the same period last year. This increase is primarily attributable to hospitals acquired during 2006 and 2005. On a same-store basis, admissions increased 1.1% and adjusted admissions increased 0.5%, compared with the same period last year. On a same-store basis, net operating revenues increased 7.7%, compared with the same period last year.
     Net operating revenues for the six months ended June 30, 2006, totaled $2.088 billion, a 14.3% increase compared with $1.827 billion for the same period last year. Income from continuing operations increased 15.1% to $109.6 million, or $1.13 per share (diluted), on 97.5 million weighted average shares outstanding for the six months ended June 30, 2006, compared with $95.2 million, or $1.01 per share (diluted), on 98.7 million weighted average shares outstanding for the same period last year. Net income increased to $106.4 million, or $1.09 per share (diluted), for the six months ended June 30, 2006, compared with $76.5 million, or $0.82 per share (diluted), for the same period last year. Loss on discontinued operations for the six months ended June 30, 2006, consists of an after-tax loss of approximately $3.2 million, or $0.03 per share (diluted), related primarily to the sale of one hospital in March of 2006, which was designated as being held for sale at December 31, 2005.
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 2
July 26, 2006
     The results for the six months ended June 30, 2006, include additional compensation expense of $6.9 million, or $0.05 per diluted share, resulting from stock-based compensation calculated under SFAS No. 123(R), “Share-Based Payment”.
     Adjusted EBITDA for the six months ended June 30, 2006, was $315.2 million, compared with $283.9 million for the same period last year, representing an 11.0% increase. Net cash provided by operating activities for the six months ended June 30, 2006, was $207.0 million, compared with $276.4 million for the same period last year.
     The consolidated financial results for the six months ended June 30, 2006, reflect a 7.4% increase in total admissions compared with the same period last year. This increase is primarily attributable to hospitals acquired during 2006 and 2005. On a same-store basis, admissions decreased 0.7% and adjusted admissions decreased 0.2%, compared with the same period last year. A less severe flu season and lower respiratory related volume contributed to these decreases compared with a strong season last year. On a same-store basis, net operating revenues increased 7.3%, compared with the same period last year.
     Commenting on the results, Wayne T. Smith, chairman, president and chief executive officer of Community Health Systems, Inc., stated, “Community Health Systems delivered another very strong financial and operating performance for the second quarter of 2006. These results reflect consistent execution of our centralized and standardized operating strategy, the successful integration of recently acquired hospitals and our continued focus on quality care.”
     On April 1, 2006, the Company completed the acquisition of two hospitals from the Baptist Health System, Birmingham, Alabama: Baptist Medical Center — DeKalb (134 beds) located in Fort Payne, Alabama, and Baptist Medical Center — Cherokee (60 beds) located in Centre, Alabama. Both hospitals are the sole providers of hospital services in their respective communities and have been renamed “DeKalb Regional Medical Center” and “Cherokee Medical Center”, respectively.
     On May 1, 2006, the Company completed the acquisition of Via Christi Oklahoma Regional Medical Center, a 148-bed acute care hospital located in Ponca City, Oklahoma. This hospital is the sole provider of hospital services in its community and has been renamed “Ponca City Medical Center”.
     On June 1, 2006, the Company completed the acquisition of Mineral Area Regional Medical Center, a 135-bed acute care hospital located in Farmington, Missouri.
     On July 1, 2006, the Company completed the acquisition of the healthcare assets of Vista Health, a non-profit corporation, which included Victory Memorial Hospital (336 licensed beds) and St. Therese Medical Center (currently utilizing 71 non-acute care beds), both located in Waukegan, Illinois and renamed “Vista Medical Center East” and “Vista Medical Center West”, respectively.
     “Our acquisition pace has been exceptionally strong through the first half of 2006,” added Smith. “As we have continued to acquire new facilities and assimilate them into our system, we have realized greater operating efficiencies while improving volumes and revenues. At the same time, we have created an opportunity to capture healthcare services that were previously sent out of the local market. Our proven ability to deliver improved results and foster positive community relations has continued to be a distinct competitive advantage for Community Health Systems. We will continue to look for opportunities to selectively acquire new hospitals.”
     Included on pages 11 and 12 of this press release is a table setting forth selected information concerning the consolidated results of the Company for the year ended December 31, 2005, and updated projected operating results of the Company for the year ending December 31, 2006.
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 3
July 26, 2006
     Located in the Nashville, Tennessee, suburb of Brentwood, Community Health Systems, Inc. is a leading operator of general acute care hospitals in non-urban communities throughout the country. Through its subsidiaries, the Company currently owns, leases or operates 76 hospitals in 22 states. Its hospitals offer a broad range of inpatient medical and surgical services, outpatient treatment and skilled nursing care. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH”.
     Community Health Systems, Inc. will hold a conference call to discuss this press release on Thursday, July 27, 2006, at 10:30 a.m. Central, 11:30 a.m. Eastern. Investors will have the opportunity to listen to a live Internet broadcast of the conference call by clicking on the Investor Relations link of the Company’s website at www.chs.net, or at www.earnings.com. To listen to the live call, please go to the website at least fifteen minutes early to register, download, and install any necessary audio software. For those who cannot listen to the live broadcast, a replay will be available shortly after the call and continue through August 27, 2006. A copy of the Company’s Form 8-K (including this press release) and conference call slide show will also be available on the Company’s website at www.chs.net.
     Statements contained in this news release regarding expected operating results, acquisition transactions and other events are forward-looking statements that involve risk and uncertainties. Actual future events or results may differ materially from these statements. Readers are referred to the documents filed by Community Health Systems, Inc. with the Securities and Exchange Commission, including the Company’s annual report on Form 10-K and current reports on Forms 8-K and 10-Q. These filings identify important risk factors and other uncertainties that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 4
July 26, 2006
COMMUNITY HEALTH SYSTEMS, INC.
Financial Highlights

(Unaudited)
(In thousands, except per share amounts)
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2006     2005 (a)     2006     2005 (a)  
Net operating revenues
  $ 1,061,054     $ 918,718     $ 2,087,616     $ 1,826,981  
 
                               
Adjusted EBITDA (e)
  $ 156,744     $ 140,152     $ 315,202     $ 283,934  
 
                               
Income from continuing operations
  $ 52,369     $ 46,150     $ 109,623     $ 95,229  
 
                               
Net income
  $ 52,369     $ 40,528     $ 106,407     $ 76,516  
 
                               
Income from continuing operations per share-basic
  $ 0.55 (b)   $ 0.52     $ 1.14 (b)   $ 1.08  
 
                               
Income from continuing operations per share-diluted
  $ 0.54 (b)   $ 0.49 (c)   $ 1.13 (b)   $ 1.01 (c)
 
                               
Net income per share — basic
  $ 0.55     $ 0.45     $ 1.11     $ 0.86  
 
                               
Net income per share — diluted
  $ 0.54     $ 0.43 (c)   $ 1.09     $ 0.82 (c)
 
                               
Weighted average number of shares outstanding — basic
    95,769       89,150       96,159       88,543  
 
                               
Weighted average number of shares outstanding — diluted
    96,870       99,329 (d)     97,537 (d)     98,713 (d)
 
                               
Net cash provided by operating activities
  $ 116,232     $ 127,686     $ 207,046     $ 276,396  
 
(a)   Pursuant to Statement of Financial Accounting Standards (“SFAS”) No. 144, the Company has restated the second quarter and six months ended June 30, 2005 financial statements and statistical results to reflect the reclassification as discontinued operations of one hospital designated as being held-for-sale during the second quarter of 2005, which was subsequently sold in March of 2006. Four hospitals were previously classified as discontinued operations in 2005.
 
(b)   Includes additional compensation expense of $0.03 per share and $0.05 per share (diluted) for the second quarter and six months ended June 30, 2006, respectively, resulting from stock-based compensation calculated under SFAS No. 123(R) “Share-Based Payment”. The Company adopted SFAS No. 123(R) beginning January 1, 2006, using the modified prospective application transition method.
 
(c)   For purposes of calculating earnings per share for the quarter ended June 30, 2005, the convertible notes are dilutive and accordingly after tax interest expense of $2.2 million per quarter is excluded from the calculation of earnings and 8.6 million shares are added to the number of shares outstanding to calculate fully diluted earnings per share.
 
(d)   Adjusted to include assumed exercise of employee stock options and assumed conversion of convertible notes. As of June 30, 2006, all of the convertible notes have been redeemed. 8,569,593 shares of common stock of the Company were issued upon conversion of the outstanding notes and $0.4 million of the notes were redeemed in exchange for cash. There was no impact on earnings per share (diluted) as a result of this conversion since weighted average number of shares outstanding-diluted for the second quarter and six months ended June 30, 2005, included the shares issuable upon conversion of the convertible notes.
(Footnotes continued on next page.)
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 5
July 26, 2006
 
(e)   EBITDA consists of income before interest, income taxes, and depreciation and amortization. Adjusted EBITDA is EBITDA adjusted to exclude discontinued operations and minority interest in earnings. The Company has from time to time sold minority interests in certain of its subsidiaries or acquired subsidiaries with existing minority interest ownership positions. The Company believes that it is useful to present adjusted EBITDA because it excludes the portion of EBITDA attributable to these third party interests and clarifies for investors the Company’s portion of EBITDA generated by continuing operations. The Company uses adjusted EBITDA as a measure of liquidity. The Company has included this measure because it believes it provides investors with additional information about the Company’s ability to incur and service debt and make capital expenditures. Adjusted EBITDA is the basis for a key component in the determination of the Company’s compliance with some of the covenants under the Company’s senior secured credit facility, as well as to determine the interest rate and commitment fee payable under the senior secured credit facility.
 
    Adjusted EBITDA is not a measurement of financial performance or liquidity under generally accepted accounting principles. It should not be considered in isolation or as a substitute for net income, operating income, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles. The items excluded from adjusted EBITDA are significant components in understanding and evaluating financial performance and liquidity. This calculation of adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.
 
    The following table reconciles adjusted EBITDA, as defined, to net cash provided by operating activities as derived directly from the consolidated financial statements for the second quarter and six months ended June 30, 2006, and 2005 (in thousands):
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2006     2005     2006     2005  
Adjusted EBITDA
  $ 156,744     $ 140,152     $ 315,202     $ 283,934  
 
                               
Interest expense, net
    (23,870 )     (23,012 )     (45,657 )     (45,793 )
 
                               
Provision for income taxes
    (32,867 )     (29,390 )     (69,165 )     (60,628 )
 
                               
Loss from operations of hospitals sold and lease termination, net of taxes
          (1,151 )     (657 )     (6,624 )
 
                               
Depreciation and amortization of discontinued operations
          709             1,600  
 
                               
Other non-cash expenses, net
    5,026       1,448       3,727       1,473  
 
                               
Net changes in operating assets and liabilities, net of effects of acquisitions
    11,199       38,930       3,596       102,434  
 
                       
 
                               
Net cash provided by operating activities
  $ 116,232     $ 127,686     $ 207,046     $ 276,396  
 
                       
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 6
July 26, 2006
COMMUNITY HEALTH SYSTEMS, INC.
Condensed Consolidated Statements of Income

(Unaudited)
(In thousands, except per share amounts)
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2006     2005     2006     2005  
Net operating revenues
  $ 1,061,054     $ 918,718     $ 2,087,616     $ 1,826,981  
 
                       
 
                               
Operating expenses:
                               
Salaries and benefits
    420,147       365,097       827,815       725,330  
Provision for bad debts
    115,704       91,582       223,295       184,633  
Supplies
    125,700       110,429       248,520       223,085  
Other operating expenses
    219,113       189,446       426,156       367,510  
Rent
    23,646       22,012       46,628       42,489  
Depreciation and amortization
    47,183       40,483       89,689       80,280  
Minority interests in earnings
    455       1,117       1,068       2,004  
 
                       
Total expenses
    951,948       820,166       1,863,171       1,625,331  
 
                       
 
                               
Income from operations
    109,106       98,552       224,445       201,650  
Interest expense, net
    23,870       23,012       45,657       45,793  
 
                       
Income from continuing operations before income taxes
    85,236       75,540       178,788       155,857  
Provision for income taxes
    32,867       29,390       69,165       60,628  
 
                       
Income from continuing operations
    52,369       46,150       109,623       95,229  
 
                       
Discontinued operations, net of taxes;
                               
Loss from operations
          (1,151 )     (657 )     (6,624 )
Loss on sale of hospitals
          (4,471 )     (2,559 )     (12,089 )
 
                       
Loss on discontinued operations
          (5,622 )     (3,216 )     (18,713 )
 
                       
 
                               
Net income
  $ 52,369     $ 40,528     $ 106,407     $ 76,516  
 
                       
Income from continuing operations per share-basic
  $ 0.55     $ 0.52     $ 1.14     $ 1.08  
 
                       
Income from continuing operations per share-diluted
  $ 0.54     $ 0.49     $ 1.13     $ 1.01  
 
                       
Net income per share — basic
  $ 0.55     $ 0.45     $ 1.11     $ 0.86  
 
                       
Net income per share — diluted
  $ 0.54     $ 0.43     $ 1.09     $ 0.82  
 
                       
Weighted average number of shares outstanding:
                               
Basic
    95,769       89,150       96,159       88,543  
 
                       
Diluted
    96,870       99,329       97,537       98,713  
 
                       
Net Income per share calculation:
                               
Net income
  $ 52,369     $ 40,528     $ 106,407     $ 76,516  
Add — Convertible notes interest, net of taxes
          2,189       135       4,378  
 
                       
Adjusted net income
  $ 52,369     $ 42,717     $ 106,542     $ 80,894  
 
                       
Weighted average number of shares outstanding — basic
    95,769       89,150       96,159       88,543  
Add effect of dilutive securities:
                               
Stock awards
    1,101       1,597       1,085       1,588  
Convertible notes
          8,582       293       8,582  
 
                       
Weighted average number of shares outstanding — diluted
    96,870       99,329       97,537       98,713  
 
                       
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 7
July 26, 2006
COMMUNITY HEALTH SYSTEMS, INC.
Selected Operating Data

(Unaudited)
($ in thousands)
                                                 
    For the Three Months Ended June 30,  
    Consolidated     Same-Store  
    2006     2005     % Change     2006     2005     % Change  
Number of hospitals (at end of period)
    75       67               67       67          
 
                                               
Licensed beds (at end of period)
    8,546       7,575               7,512       7,575          
 
                                               
Beds in service (at end of period)
    6,874       6,187               6,186       6,187          
 
                                               
Admissions
    78,248       70,844       10.5 %     71,634       70,844       1.1 %
 
                                               
Adjusted admissions
    147,223       132,764       10.9 %     133,410       132,764       0.5 %
 
                                               
Patient days
    321,573       293,320       9.6 %     297,178       293,320       1.3 %
 
                                               
Average length of stay (days)
    4.1       4.1               4.1       4.1          
 
                                               
Occupancy rate (average beds in service)
    52.1 %     52.2 %             52.8 %     52.2 %        
 
                                               
Net operating revenues
  $ 1,061,054     $ 918,718       15.5 %   $ 989,537     $ 918,815       7.7 %
 
                                               
Net inpatient revenue as a % of total net operating revenues
    49.8 %     50.4 %             50.0 %     50.4 %        
 
                                               
Net outpatient revenue as a % of total net operating revenues
    48.9 %     48.4 %             48.7 %     48.4 %        
 
                                               
Income from operations
  $ 109,106     $ 98,552       10.7 %   $ 106,301     $ 99,736       6.6 %
 
                                               
Income from operations as a % of net operating revenues
    10.3 %     10.7 %             10.7 %     10.9 %        
 
                                               
Depreciation and amortization
  $ 47,183     $ 40,483             $ 43,628     $ 39,594          
 
                                               
Minority interest in earnings
  $ 455     $ 1,117             $ 455     $ 1,117          
 
                                               
Liquidity Data:
                                               
 
                                               
Adjusted EBITDA
  $ 156,744     $ 140,152       11.8 %                        
 
                                               
Adjusted EBITDA as a % of net operating revenues
    14.8 %     15.3 %                                
 
                                               
Net cash provided by operating activities
  $ 116,232     $ 127,686                                  
 
                                               
Net cash provided by operating activities as a % of net operating revenue
    11.0 %     13.9 %                                
 
    Continuing operating results and statistical data exclude discontinued operations for all periods presented.
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 8
July 26, 2006
COMMUNITY HEALTH SYSTEMS, INC.
Selected Operating Data

(Unaudited)
($ in thousands)
                                                 
    For the Six Months Ended June 30,  
    Consolidated     Same-Store  
    2006     2005     % Change     2006     2005     % Change  
Number of hospitals (at end of period)
    75       67               67       67          
 
                                               
Licensed beds (at end of period)
    8,546       7,575               7,512       7,575          
 
                                               
Beds in service (at end of period)
    6,874       6,187               6,186       6,187          
 
                                               
Admissions
    157,214       146,334       7.4 %     145,337       146,334       -0.7 %
 
                                               
Adjusted admissions
    290,305       267,320       8.6 %     266,674       267,320       -0.2 %
 
                                               
Patient days
    654,822       612,819       6.9 %     607,444       612,819       -0.9 %
 
                                               
Average length of stay (days)
    4.2       4.2               4.2       4.2          
 
                                               
Occupancy rate (average beds in service)
    54.2 %     55.4 %             54.8 %     55.4 %        
 
                                               
Net operating revenues
  $ 2,087,616     $ 1,826,981       14.3 %   $ 1,959,573     $ 1,826,968       7.3 %
 
                                               
Net inpatient revenue as a % of total net operating revenues
    50.3 %     51.2 %             50.4 %     51.2 %        
 
                                               
Net outpatient revenue as a % of total net operating revenues
    48.4 %     47.7 %             48.3 %     47.7 %        
 
                                               
Income from operations
  $ 224,445     $ 201,650       11.3 %   $ 222,179     $ 203,038       9.4 %
 
                                               
Income from operations as a % of net operating revenues
    10.8 %     11.0 %             11.3 %     11.1 %        
 
                                               
Depreciation and amortization
  $ 89,689     $ 80,280             $ 83,972     $ 79,222          
 
                                               
Minority interest in earnings
  $ 1,068     $ 2,004             $ 345     $ 2,004          
 
                                               
Liquidity Data:
                                               
 
                                               
Adjusted EBITDA
  $ 315,202     $ 283,934       11.0 %                        
 
                                               
Adjusted EBITDA as a % of net operating revenues
    15.1 %     15.5 %                                
 
                                               
Net cash provided by operating activities
  $ 207,046     $ 276,396                                  
 
                                               
Net cash provided by operating activities as a % of net operating revenue
    9.9 %     15.1 %                                
 
    Continuing operating results and statistical data exclude discontinued operations for all periods presented.
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 9
July 26, 2006
COMMUNITY HEALTH SYSTEMS, INC.
Condensed Consolidated Balance Sheets

(Unaudited)
(in thousands)
                 
    June 30,     December 31,  
    2006     2005  
ASSETS
               
Current assets
               
Cash and cash equivalents
  $ 24,157     $ 104,108  
Patient accounts receivable, net of allowance for doubtful accounts of $350,776 and $346,024 at June 30, 2006, and December 31, 2005, respectively
    727,688       656,029  
Supplies
    102,874       95,200  
Deferred income taxes
    4,128       4,128  
Prepaid expenses and taxes
    31,188       33,377  
Other current assets
    49,608       36,494  
 
           
Total current assets
    939,643       929,336  
 
           
 
               
Property and equipment
    2,335,763       2,128,639  
Less accumulated depreciation and amortization
    (578,545 )     (517,648 )
 
           
Property and equipment, net
    1,757,218       1,610,991  
 
           
Goodwill
    1,316,939       1,259,816  
 
           
Other assets, net
    164,860       149,202  
 
           
Total assets
  $ 4,178,660     $ 3,949,345  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities
               
Current maturities of long-term debt
  $ 20,621     $ 19,124  
Accounts payable
    197,010       189,940  
Current income taxes payable
    50,289       19,811  
Accrued interest
    6,877       8,591  
Accrued liabilities
    258,989       215,064  
 
           
Total current liabilities
    533,786       452,530  
 
           
Long-term debt
    1,656,983       1,648,500  
 
           
Deferred income taxes
    157,579       157,579  
 
           
Other long-term liabilities
    132,013       126,159  
 
           
Stockholders’ equity
               
Preferred stock, $.01 par value per share, 100,000,000 shares authorized, none issued
           
Common stock, $.01 par value per share, 300,000,000 shares authorized; 95,832,809 shares issued and 94,857,260 shares outstanding at June 30, 2006, and 94,539,837 shares issued and 93,564,288 shares outstanding at December 31, 2005
    958       945  
Additional paid-in capital
    1,215,495       1,208,930  
Treasury stock, at cost, 975,549 shares at June 30, 2006 and December 31, 2005
    (6,678 )     (6,678 )
Unearned stock-based compensation
          (13,204 )
Accumulated other comprehensive income
    22,724       15,191  
Retained earnings
    465,800       359,393  
 
           
Total stockholders’ equity
    1,698,299       1,564,577  
 
           
Total liabilities and stockholders’ equity
  $ 4,178,660     $ 3,949,345  
 
           
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 10
July 26, 2006
COMMUNITY HEALTH SYSTEMS, INC.
Condensed Consolidated Statements of Cash Flows

(Unaudited)
(in thousands)
                 
    Six Months Ended  
    June 30,  
    2006     2005  
Cash flows from operating activities
               
Net income
  $ 106,407     $ 76,516  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    89,689       81,880  
Minority interest in earnings
    1,068       2,004  
Equity-based compensation expense
    8,946       1,984  
Loss on sale of hospitals
    3,937       6,295  
Impairment on hospital held for sale
          6,718  
Excess tax benefits relating to stock-based compensation
    (4,588 )      
Other non-cash expenses, net
    (635 )     (511 )
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
               
Patient accounts receivable
    (57,961 )     (16,717 )
Supplies, prepaid expenses and other current assets
    (93 )     (649 )
Accounts payable, accrued liabilities and income taxes
    69,988       90,867  
Other
    (9,712 )     28,009  
 
           
Net cash provided by operating activities
    207,046       276,396  
 
           
 
               
Cash flows from investing activities
               
Acquisitions of facilities and other related equipment
    (178,015 )     (45,813 )
Purchases of property and equipment
    (94,194 )     (76,735 )
Disposition of hospitals
    750       51,861  
Proceeds from sale of equipment
    74       2,155  
Increase in other assets
    (24,382 )     (22,079 )
 
           
Net cash used in investing activities
    (295,767 )     (90,611 )
 
           
 
               
Cash flows from financing activities
               
Proceeds from exercise of stock options
    8,699       35,900  
Excess tax benefits relating to stock-based compensation
    4,588        
Stock buy-back
    (137,666 )     (11,214 )
Deferred financing costs
    (16 )     (991 )
Redemption of convertible notes
    (128 )      
Proceeds from minority investors in joint ventures
    3,060       1,383  
Redemption of minority investments in joint ventures
    (530 )     (317 )
Distributions to minority investors in joint ventures
    (1,977 )     (979 )
Borrowings under credit agreement
    176,000        
Repayments of long-term indebtedness
    (43,260 )     (19,701 )
 
           
Net cash provided by financing activities
    8,770       4,081  
 
           
 
               
Net change in cash and cash equivalents
    (79,951 )     189,866  
 
               
Cash and cash equivalents at beginning of period
    104,108       82,498  
 
           
 
               
Cash and cash equivalents at end of period
  $ 24,157     $ 272,364  
 
           
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 11
July 26, 2006
Regulation FD Disclosure
     The following table sets forth selected information concerning the consolidated operating results of the Company for the year ended December 31, 2005, and the Company’s updated projected consolidated operating results of the Company for the year ending December 31, 2006. These projections are based on the Company’s historical operating performance, current trends and other assumptions that the Company believes are reasonable at this time.
     The following is provided as guidance to analysts and investors:
                 
    2005    
    Actual Results    
    Adjusted    
    for Pro-forma Effect   Updated
    of Stock-Based   2006
    Compensation   Projection
    Expense   Range
Net operating revenues (in millions)
  $ 3,738     $ 4,275 to $4,325  
Adjusted EBITDA (in millions)
  $ 556     $ 625 to $645  
Income from continuing operations per share — diluted
  $ 1.91     $ 2.17 to $2.22  
Same hospitals annual admissions growth
    2.1 %   1.0% to 2.0%
Weighted average diluted shares (in millions)
    98.6       96 to 97  
Acquisitions of new hospitals
    5       6 to 7  
 
               
Income from Continuing Operations Per Share — Diluted:
               
1st quarter ended March 31
  $ 0.50     $ 0.58 (actual) 
2nd quarter ended June 30
  $ 0.46     $ 0.54 (actual) 
3rd quarter ending September 30
  $ 0.44     $ 0.50 to $0.51  
4th quarter ending December 31
  $ 0.51     $ 0.56 to $0.58  
     The following assumptions were used in developing the guidance provided above:
  On January 1, 2006, the Company adopted SFAS No. 123(R), using the modified prospective application transition method. For the year ending December 31, 2006, the Company anticipates recognizing stock — based compensation expense of approximately $20 million, or $0.13 per diluted share, as compared to $5 million, or $0.03 per diluted share, recognized for the year ended December 31, 2005, under APB No. 25. Thus, the 2006 projected results do include additional stock — based compensation expense of $15 million, or $0.10 per diluted share. For comparative purposes, the 2005 actual results have been restated to include pro-forma stock-based stock option compensation expense of $17.6 million, or $0.11 per share (diluted) as if SFAS No. 123(R) was adopted on January 1, 2005, and reflected in the Company’s reported earnings for 2005. Adjusted EBITDA and income from continuing operations per share — diluted, as reported in 2005 were $573.2 million and $2.02 per share, respectively. The quarterly income from continuing operations per share-diluted, as reported in 2005 were $0.52 (1st qtr.), $0.49 (2nd qtr.), $0.47 (3rd qtr.) and $0.54 (4th qtr.).
 
  Expressed as a percentage of net operating revenue, provision for bad debts is projected to be approximately 10.5% to 11.0% for 2006.
 
  Capital expenditures are as follows (in millions):
                 
            Updated
    Actual   Guidance
    2005   2006
Total
  $ 200     $ 260 to $275  
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 12
July 26, 2006
  Expressed as a percent of net operating revenues, total depreciation and amortization is projected to be approximately 4.2% to 4.6% for 2006; however, this is a fixed cost and the percentages may vary as revenue varies. The adoption on January 1, 2006, of FASB Interpretation No. 45-3 (Entitled Minimum Revenue Guarantees Granted to a Business or Its Owners), requiring the Company to begin capitalizing and amortizing certain elements of its physician recruitment costs, is not expected to have a material impact on earnings during 2006.
 
  Expressed as a percentage of income before income taxes, provision for income tax is projected to be approximately 38.3% to 38.7% for 2006.
 
.   The Company is exposed to London Inter-Bank Offer Rate (“LIBOR”) based interest rates, which have been increasing over the past two years. The following is a summary of the three-month LIBOR rates at various dates:
         
December 31, 2003
    1.15188 %
December 31, 2004
    2.56438 %
December 31, 2005
    4.53625 %
June 30, 2006
    5.48063 %
    To partially offset the rise in LIBOR rates, the Company is currently a party to ten separate interest swap agreements to limit the effect of changes in interest rates on a portion of the Company’s long-term borrowings. On each of the swaps, the Company receives a variable rate of interest based on the three-month LIBOR, in exchange for the payment by the Company of a fixed rate of interest. Currently, the Company pays on a quarterly basis a margin above LIBOR of 175 basis points for revolver loans and term loans under the senior secured credit facility. For the purpose of providing 2006 projection range guidance, the Company has assumed that future LIBOR rates for borrowings under the Company’s $1.625 billion Senior Secured Credit Facility will increase based on market quotations of the forward yield curve and other economic forecasts.
 
  On December 16, 2005, the Company announced an open market repurchase program for up to five million shares of the Company’s common stock not to exceed $200 million in purchases. This repurchase program commenced January 14, 2006, and will conclude at the earlier of three years or when the maximum number of shares has been repurchased or the maximum dollar amount has been reached. Through June 30, 2006, the Company had repurchased pursuant to this repurchase plan 3,824,800 shares at a weighted-average price of $35.95 per share. The maximum number of shares that may still be purchased under the repurchase program is 1,175,200. The remaining maximum dollar amount of shares that is permitted to be purchased under the Company’s existing indebtedness is $41.0 million. The assumed interest expense and weighted average diluted shares set forth in this guidance reflect the impact of this stock repurchase program.
 
  The following table reconciles adjusted EBITDA, as defined, to the Company’s estimated net cash provided by operating activities as presented in the guidance shown on page 11:
                 
    2005    
    Actual Results    
    Adjusted for    
    Pro-forma   Updated
    Stock-Based   2006 Projection
    Compensation   Range
    Expense   (in millions)
Adjusted EBITDA
  $ 556     $ 625 to $645  
Taxes and interest expense
    (209 )   (226) to (235)
Other non-cash expenses and net changes in operating assets and liabilities
    64       31 to 40  
 
               
Net cash provided by operating activities
  $ 411     $ 430 to $450  
 
               
     The projections set forth in this report constitute forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Although the Company believes that these forward-looking statements are based on reasonable
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 13
July 26, 2006
assumptions, these assumptions are inherently subject to significant economic and competitive uncertainties and contingencies, which are difficult or impossible to predict accurately and are beyond the control of the Company. Accordingly, the Company cannot give any assurance that its expectations will in fact occur and cautions that actual results may differ materially from those in the forward-looking statements. A number of factors could affect the future results of the Company or the healthcare industry generally and could cause the Company’s expected results to differ materially from those expressed in this filing.
These factors include, among other things:
  general economic and business conditions, both nationally and in the regions in which we operate;
 
  demographic changes;
 
  existing governmental regulations and changes in, or the failure to comply with, governmental regulations;
 
  legislative proposals for healthcare reform;
 
  the impact of the Medicare Prescription Drug, Improvement and Modernization Act of 2003, which includes specific reimbursement changes for small urban and non-urban hospitals;
 
  our ability, where appropriate, to enter into managed care provider arrangements and the terms of these arrangements;
 
  changes in inpatient or outpatient Medicare and Medicaid payment levels;
 
  uncertainty regarding the application of the Health Insurance Portability and Accountability Act of 1996 regulations;
 
  increases in wages as a result of inflation or competition for highly technical positions and rising supply cost due to market pressure from pharmaceutical companies and new product releases;
 
  liability and other claims asserted against us, including self-insured malpractice claims;
 
  competition;
 
  our ability to attract and retain qualified personnel, key management, physicians, nurses and other health care workers;
 
  trends toward treatment of patients in less acute or specialty healthcare settings, including ambulatory surgery centers or specialty hospitals;
 
  changes in medical or other technology;
 
  changes in generally accepted accounting principles;
 
  the availability and terms of capital to fund additional acquisitions or replacement facilities;
 
  our ability to successfully acquire and integrate additional hospitals;
 
  our ability to obtain adequate levels of general and professional liability insurance;
 
  potential adverse impact of known and unknown government investigations;
 
  timeliness of reimbursement payments received under government programs; and
 
  the other risk factors set forth in our public filings with the Securities and Exchange Commission.
- MORE -

 


 

CYH Announces Second Quarter 2006 Results
Page 14
July 26, 2006
     The consolidated operating results for the quarter and six months ended June 30, 2006, are not necessarily indicative of the results that may be experienced for any such future period or for any future fiscal year, including this fiscal year.
     The Company cautions that the projections for calendar year 2006 set forth herein are given as of the date hereof based on currently available information. The Company is not undertaking any obligation to update these projections as conditions change or other information becomes available.
- END -